Correlation Between Dupont De and Vicore Pharma

Can any of the company-specific risk be diversified away by investing in both Dupont De and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dupont De Nemours and Vicore Pharma Holding, you can compare the effects of market volatilities on Dupont De and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Vicore Pharma.

Diversification Opportunities for Dupont De and Vicore Pharma

-0.31

Correlation Coefficient

Dupont De  Vicore Pharma

Very good diversification

The 3 months correlation between Dupont and Vicore is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of Dupont De i.e., Dupont De and Vicore Pharma go up and down completely randomly.

Pair Corralation between Dupont De and Vicore Pharma

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.52 times more return on investment than Vicore Pharma. However, Dupont De Nemours is 1.91 times less risky than Vicore Pharma. It trades about -0.01 of its potential returns per unit of risk. Vicore Pharma Holding is currently generating about -0.07 per unit of risk. If you would invest  7,557  in Dupont De Nemours on December 29, 2024 and sell it today you would lose (154.00) from holding Dupont De Nemours or give up 2.04% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Dupont De Nemours  vs.  Vicore Pharma Holding

Dupont De Nemours

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dupont De Nemours has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Vicore Pharma Holding

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vicore Pharma Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Dupont De and Vicore Pharma

The main advantage of trading using opposite Dupont De and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.

The idea behind Dupont De Nemours and Vicore Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.